- D2PM
- Diphenylprolinol
Corkery, JM; Elliott, S; Schifano, F; Corazza, O; Ghodse, AH. 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review Prog. Neuro-Psychopharmacol. Biol. Psych., 3 Dec 2012, 39 (2), 253–258. 347 kB. https://doi.org/10.1016/j.pnpbp.2012.05.021
Lidder, S; Dargan, PI; Sexton, M; Button, J; Ramsey, J; Holt, DW; Wood, DM. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]) J. Med. Toxicol., 1 Sep 2008, 4 (3), 167–169. 164 kB. https://doi.org/10.1007/BF03161195
Wood, DM; Dargan, PI. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP) Clin. Toxicol., 1 Sep 2012, 50 (8), 727–732. 117 kB. https://doi.org/10.3109/15563650.2012.716158
Zuba, D; Byrska, B. Prevalence and co-existence of active components of ‘legal highs’ Drug Test. Anal., 1 Jun 2013, 5 (6), 420–429. 1.3 MB. https://doi.org/10.1002/dta.1365
EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.
Leffler, AM; Smith, PB; de Armas, A; Dorman, FL. The analytical investigation of synthetic street drugs containing cathinone analogs Forensic Sci. Int., 1 Jan 2014, 234, 50-56. 973 kB. https://doi.org/10.1016/j.forsciint.2013.08.021 MS
Yoshida, M; Suzuki, J; Takahashi, M; Moriyasu, T; Nakajima, J; Kanai, C; Nagashima, M; Seto, T; Shimizu, M; Hamano, T; Nakae, D. Investigations of designated substances detected from April 2010 to March 2011 Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2011, 62 107–114. 790 kB. #D2PM GC,LC,MS,UV
Nagashima, M; Seto, T; Suzuki, J. Analyses of uncontrolled drugs purchased from April 2007 to March 2008 and newly found compounds Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2008, 59 71–77. 743 kB. #diphenylpyrrolinol LC,NMR,UV
EMCDDA. New drugs in Europe, 2007, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2008. 381 kB. #5
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Other D2PM
Simmler, LD; Rickli, A; Schramm, Y; Hoener, MC; Liechti, ME. Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives Biochem. Pharmacol., 15 Mar 2014, 88 (2), 237–244. 504 kB. https://doi.org/10.1016/j.bcp.2014.01.024 #D2PM